PubRank

Valérie Pittet

Author PubWeight™ 24.03‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rate. Am J Gastroenterol 2013 2.05
2 Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol 2010 1.69
3 Epidemiology of inflammatory bowel disease: Is there a shift towards onset at a younger age? J Pediatr Gastroenterol Nutr 2011 1.56
4 Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes. Inflamm Bowel Dis 2013 1.51
5 Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease. Inflamm Bowel Dis 2011 1.41
6 Extraintestinal manifestations of Crohn's disease. Digestion 2008 0.93
7 Upper gastrointestinal Crohn's disease. Digestion 2008 0.93
8 Use of the World Wide Web to implement clinical practice guidelines: a feasibility study. J Med Internet Res 2003 0.91
9 Fibrostenotic Crohn's disease. Digestion 2008 0.88
10 Mood and nonmood components of perceived stress and exacerbation of Crohn's disease. Inflamm Bowel Dis 2011 0.87
11 Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals. J Crohns Colitis 2010 0.86
12 Pregnancy and breastfeeding in patients with Crohn's disease. Digestion 2008 0.85
13 Effects of social support on the clinical course of Crohn's disease. Inflamm Bowel Dis 2010 0.84
14 Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT II. J Crohns Colitis 2009 0.82
15 Characteristics of non-responders to self-reported questionnaires in a large inflammatory bowel disease cohort study. Scand J Gastroenterol 2015 0.81
16 Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel - EPACT II. J Crohns Colitis 2009 0.81
17 Appropriateness of therapy for active Crohn's disease: Results of a multidisciplinary international expert panel-EPACT II. J Crohns Colitis 2009 0.80
18 Drug safety in Crohn's disease therapy. Digestion 2008 0.79
19 Infliximab for Crohn's disease in the Swiss IBD Cohort Study: clinical management and appropriateness. Eur J Gastroenterol Hepatol 2010 0.79
20 Severe and steroid-resistant Crohn's disease. Digestion 2008 0.79
21 Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study. J Crohns Colitis 2007 0.79
22 Fistulizing Crohn's disease. Digestion 2008 0.78
23 Appropriateness of early management of newly diagnosed Crohn's disease in a European population-based cohort. Scand J Gastroenterol 2010 0.78
24 Maintenance of surgically induced remission of Crohn's disease. Digestion 2008 0.77
25 Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up. Eur J Gastroenterol Hepatol 2017 0.76
26 Endoscope once for any symptom at any age? Gastrointest Endosc 2007 0.75
27 Acceptance of inflammatory bowel disease treatment recommendations based on appropriateness ratings: do practicing gastroenterologists agree with experts? J Crohns Colitis 2015 0.75
28 [Life-threatening emergencies at the office: implications for medical education and equipment of the primary care physician]. Rev Med Suisse 2008 0.75
29 Prevalence and Determinants of Job Stress in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis 2017 0.75
30 Low prevalence of behavioural and emotional problems among Swiss paediatric patients with inflammatory bowel disease. Arch Dis Child 2012 0.75
31 Maintenance of medically induced remission of Crohn's disease. Digestion 2008 0.75
32 Mild-to-moderate active luminal Crohn's disease. Digestion 2008 0.75
33 Appropriate maintenance treatment for Crohn's disease: Results of a multidisciplinary international expert panel - EPACT II. J Crohns Colitis 2009 0.75
34 EPACT II: project and methods. Digestion 2008 0.75
35 Analysis of TNF-antagonist switch over time and associated risk factors in the Swiss Inflammatory Bowel Disease Cohort. Scand J Gastroenterol 2014 0.75